NEW YORK (GenomeWeb News) – Verdezyne said that it will optimize selected genes that encode industrial enzymes for Novozymes, under a contract announced today.

Verdezyne, the Carlsbad, Calif.-based firm that was formerly called Coda Genomics, uses computational methods to design and synthesize gene libraries for engineering proteins, metabolic pathways, and microorganisms. Its technologies are used to optimize commercial fermentation processes, which are applied to manufacturing platform chemicals and biofuels.

Terms of the contract were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.